Abstract: A microbial inoculant composition including aquatic bacterial species. In some embodiments, the microbial inoculant composition includes at least one of an aquatic Pseudomonas spp. and a Clostridium spp.

Abstract: A microbial inoculant composition includes aquatic bacterial species. In some embodiments, the microbial inoculant composition includes at least one of an aquatic Pseudomonas spp. and a Clostridium spp.

Abstract: Embodiments of the present disclosure generally relate to devices, methods and systems for dispensing solid forms of an agent to a subject. In some embodiments an agent disclosed herein can include a pharmaceutical, biological or other solid agent for dispensing to a subject in need thereof. In certain embodiments, the present disclosure describes devices, methods and systems for biometric data acquisition and monitoring before, during, and/or after dispensing solid dosage forms of an agent to a subject. In some embodiments, these devices can be portable and/or handheld devices.

Abstract: Embodiments of the present invention relate generally to determining compliance and/or efficacy of a dosing regimen of a pharmaceutical or other monitored agent to a subject. In certain embodiments, the present disclosure provides devices and methods for biometric data acquisition and monitoring before, during, or after administration of a pharmaceutical or other monitored agent to a user. Other embodiments of the present invention improve patient outcomes by giving patients more control over the delivery of their medication and by providing physicians with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, biological or other monitored agents to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after administration of pharmaceutical, biological or other monitored agents. Embodiments of the present disclosure can improve health outcome of a subject, for example, by giving patients more control over the delivery of their medication and by providing healthcare professionals with meaningful and more accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, monitored and/or biological agents via nebulization to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after the nebulization and administration of pharmaceutical, monitored and/or biological agents to a subject. In yet other embodiments, devices, systems and methods disclosed herein provide for delivery of agents where patients have an increased level of control over the delivery of their medication and by providing healthcare providers with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: A microbial inoculant composition includes aquatic bacterial species. In some embodiments, the microbial inoculant composition includes at least one of an aquatic Pseudomonas spp. and a Clostridium spp.

Abstract: A microbial inoculant composition includes aquatic bacterial species. In some embodiments, the microbial inoculant composition includes at least one of an aquatic Pseudomonas spp. and a Clostridium spp.

Abstract: Embodiments of the present invention relate generally to determining compliance and/or efficacy of a dosing regimen of a pharmaceutical or other monitored agent to a subject. In certain embodiments, the present disclosure provides devices and methods for biometric data acquisition and monitoring before, during, or after administration of a pharmaceutical or other monitored agent to a user. Other embodiments of the present invention improve patient outcomes by giving patients more control over the delivery of their medication and by providing physicians with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, biological or other monitored agents to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after administration of pharmaceutical, biological or other monitored agents. Embodiments of the present disclosure can improve health outcome of a subject, for example, by giving patients more control over the delivery of their medication and by providing healthcare professionals with meaningful and more accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure generally relate to devices, methods and systems for dispensing solid forms of an agent to a subject. In some embodiments an agent disclosed herein can include a pharmaceutical, biological or other solid agent for dispensing to a subject in need thereof. In certain embodiments, the present disclosure describes devices, methods and systems for biometric data acquisition and monitoring before, during, and/or after dispensing solid dosage forms of an agent to a subject. In some embodiments, these devices can be portable and/or handheld devices.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, monitored and/or biological agents via nebulization to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for bio-metric and diagnostic data acquisition and patient monitoring before, during, and after the nebulization and administration of pharmaceutical, monitored and/or biological agents to a subject. In yet other embodiments, devices, systems and methods disclosed herein provide for delivery of agents where patients have an increased level of control over the delivery of their medication and by providing healthcare providers with meaningful and accurate biomctric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure relate to systems and methods for ethanol production, use, and waste recovery using aquatic plants. In certain embodiments, systems and methods are disclosed for reuse and further processing of waste alcohols, sugars, organic acids and/or byproducts produced by conversion of corn, other grains, or other biomass materials of use in biofuel production methods.

Abstract: Embodiments of the present disclosure generally relate to compositions and methods for enhancing or accelerating plant growth and/or plant productivity. In certain embodiments, compositions and methods disclosed herein concern enhancing growth of terrestrial crops using compositions containing liquid media or growth substrate conditioned by a submersible plant. Other embodiments relate to formulations combining PGPB and various agents that activate and/or promote adhesion of the PGPB to subject plants to improve growth. Still other embodiments relate to improved methods for applying the compositions and formulations disclosed herein to various terrestrial plants.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, monitored and/or biological agents via nebulization to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after the nebulization and administration of pharmaceutical, monitored and/or biological agents to a subject. In yet other embodiments, devices, systems and methods disclosed herein provide for delivery of agents where patients have an increased level of control over the delivery of their medication and by providing healthcare providers with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present disclosure generally relate to devices, methods and systems for dispensing solid forms of an agent to a subject. In some embodiments an agent disclosed herein can include a pharmaceutical, biological or other solid agent for dispensing to a subject in need thereof. In certain embodiments, the present disclosure describes devices, methods and systems for biometric data acquisition and monitoring before, during, and/or after dispensing solid dosage forms of an agent to a subject. In some embodiments, these devices can be portable and/or handheld devices.

Abstract: Embodiments of the present disclosure relate generally to devices and systems for administering pharmaceutical, biological or other monitored agents to a subject. In certain embodiments, the present disclosure provides devices, methods and systems for biometric and diagnostic data acquisition and patient monitoring before, during, and after administration of pharmaceutical, biological or other monitored agents. Embodiments of the present disclosure can improve health outcome of a subject, for example, by giving patients more control over the delivery of their medication and by providing healthcare professionals with meaningful and more accurate biometric and diagnostic data during treatment.

Abstract: Embodiments of the present invention relate generally to determining compliance and/or efficacy of a dosing regimen of a pharmaceutical or other monitored agent to a subject. In certain embodiments, the present disclosure provides devices and methods for biometric data acquisition and monitoring before, during, or after administration of a pharmaceutical or other monitored agent to a user. Other embodiments of the present invention improve patient outcomes by giving patients more control over the delivery of their medication and by providing physicians with meaningful and accurate biometric and diagnostic data during treatment.

Abstract: Methods and systems for collecting, purifying, and/or extracting ethanol produced during anaerobic metabolism by aquatic plants is provided. The system includes a cell containing water and an aquatic plant, an ethanol extraction assembly in fluid communication with the cell for removing ethanol from the water. Ethanol is released by the aquatic plant by initiating an anaerobic process in the plant such as by regulating the photosynthesis inducing light that reaches the aquatic plant.

Abstract: Methods and systems for growing aquatic plants and collecting, purifying, and/or extracting ethanol produced during anaerobic metabolism by aquatic plants are provided. The system includes a cell containing water and an aquatic plant, an ethanol extraction assembly in fluid communication with the cell for removing ethanol from the water. Ethanol is released by the aquatic plant by initiating an anaerobic process in the plant such as by regulating the photosynthesis inducing light that reaches the aquatic plant.